In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.

Published

Journal Article

SOURCE CITATION: Gimbel M, Qaderdan K, Willemsen L, et al. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet. 2020;395:1374-81. 32334703.

Full Text

Duke Authors

Cited Authors

  • Kelsey, MD; Newby, LK

Published Date

  • September 15, 2020

Published In

Volume / Issue

  • 173 / 6

Start / End Page

  • JC28 -

PubMed ID

  • 32926825

Pubmed Central ID

  • 32926825

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/ACPJ202009150-028

Language

  • eng

Conference Location

  • United States